Skip to Content
Merck

C4255

Creatinine

anhydrous, ≥98%

Synonym(s):

2-Amino-1-methyl-2-imidazolin-4-one, 2-Imino-1-methylimidazolidin-4-one, 2-Imino-N-methylhydantoin

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C4H7N3O
CAS Number:
60-27-5
Molecular Weight:
113.12
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
24892677
EC Number:
200-466-7
Beilstein/REAXYS Number:
112061
MDL number:
MFCD00059730
Assay:
≥98%
Form:
powder

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

DDRJAANPRJIHGJ-UHFFFAOYSA-N

InChI

1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)

SMILES string

CN1CC(=O)N=C1N

grade

anhydrous

assay

≥98%

form

powder

mp

295 °C (dec.) (lit.)

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Creatinine is a breakdown product formed by the degradation of creatine phosphate from muscles. The kidneys extract creatinine from the body by filtering almost all of it from the blood and excreting it in the urine. Serum creatinine is the most commonly used indicator for renal functioning. In chemical synthesis, creatinine is used as a heterocyclic nitrogenous compound that produces electron-rich and highly basic creatinine derivatives.

Application

Creatinine can be used as:
  • A nitrogen donor building block to prepare nitrogen-containing heterocyclic derivatives.
  • A reactant to synthesize donor-acceptor type carbon nitride copolymer, which is used as a photocatalyst in hydrogen production.
  • A starting material to prepare creatol(2-amino-1,5-dihydro-5-hydroxy methylimidazol-4-one) via creatinine chloramine.
  • A reactant to synthesize 3-substituted-3-hydroxyisatins by gold-catalyzed aldolization with various isatins.

wgk

WGK 3

flash_point_f

554.0 °F - closed cup

flash_point_c

290 °C - closed cup

ppe

Eyeshields, Gloves, type N95 (US)

Storage Class

11 - Combustible Solids

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

C4255-10G: + C4255-10MG: + C4255-1KG: + C4255-25G: + C4255-VAR: + C4255-BULK: + C4255-100G: + C4255-1G:

jan

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SLCK3540
SLCG9637
SLCF3194
SLCF5841
SLBW4791

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Study of Creatinine and its 5-Alkoxy Analogs: Structure and Conformational Studies in the Solid and Solution States by X-Ray Crystallography, NMR, UV and Mass Spectrometry
Arakali AV, et al.
Nucleosides, nucleotides & nucleic acids, 16(12), 2193-2218 (1997)
A Simple Conversion of Creatinine to Creatol via Creatinine Chloroamine
Ienaga K, et al.
Australian Journal of Chemistry, 68(2), 248-253 (2015)
Karel G M Moons et al.
Annals of internal medicine, 162(1), W1-73 (2015-01-07)
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes.
Richard E Gilbert et al.
Diabetologia, 57(7), 1325-1331 (2014-04-29)
As glycaemia and the incidence of microvascular diabetes complications follow a log-linear relationship, it becomes increasingly difficult to demonstrate a microvascular benefit of glucose-lowering when the HbA1c level is close to normal. The Outcome Reduction with an Initial Glargine Intervention
Norishige Yoshikawa et al.
Kidney international, 87(1), 225-232 (2014-07-24)
In this multicenter, open-label, randomized controlled trial, we determined whether 2-month prednisolone therapy for steroid-sensitive nephrotic syndrome was inferior or not to 6-month therapy despite significantly less steroid exposure. The primary end point was time from start of initial treatment
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service